Start with your question. Search first, choose the closest subject and keep personal details private. Posting guidelines
Notifications
Clear all
Peptides & Research Compounds
3
Posts
3
Users
0
Reactions
361
Views
Topic starter
25/01/2021 3:17 am
Bremelanotide (PT-141) and the reconstitution argument. Half the threads on this are arguing past each other about arithmetic.
The animal data is stronger than the human data and the human data is not nothing, it is just small.
What surprised me is how much of the perceived benefit was routine and attention rather than pharmacology.
Sample size, blinding, and who paid for it. Those three questions kill most of the confidence in most of these threads.
I would rather have a narrow conclusion and be right than a broad one and be interesting.
Curious whether the popular dose has any basis or is just the convenient one.
25/01/2021 4:45 am
If it needs three other compounds to notice, you have not tested the first one. Same for me with PT-141, unfortunately.
25/01/2021 5:22 am
Same here.